Prelude Therapeutics Inc. (PRLD): Price and Financial Metrics
PRLD Price/Volume Stats
| Current price | $1.03 | 52-week high | $6.80 |
| Prev. close | $0.98 | 52-week low | $0.61 |
| Day low | $0.94 | Volume | 122,500 |
| Day high | $1.04 | Avg. volume | 197,947 |
| 50-day MA | $0.84 | Dividend yield | N/A |
| 200-day MA | $1.49 | Market Cap | 58.15M |
PRLD Stock Price Chart Interactive Chart >
Prelude Therapeutics Inc. (PRLD) Company Bio
Prelude Therapeutics, Inc. operates as a cancer drug discovery company. It focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Gopi Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
PRLD Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PRLD Price Returns
| 1-mo | 25.96% |
| 3-mo | 39.95% |
| 6-mo | 0.00% |
| 1-year | -72.53% |
| 3-year | -79.80% |
| 5-year | N/A |
| YTD | -19.22% |
| 2024 | -70.14% |
| 2023 | -29.30% |
| 2022 | -51.49% |
| 2021 | -82.60% |
| 2020 | N/A |